![John Dickson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Dickson
Chief Tech/Sci/R&D Officer at Interpharma Investments Ltd.
Network origin in John Dickson first degree
Entity | Entity type | Industry | |
---|---|---|---|
Interpharma Investments Ltd.
![]() Interpharma Investments Ltd. Pharmaceuticals: MajorHealth Technology Interpharma Investments Ltd. operates as a holding company with interest in the distribution and manufacturing of pharmaceutical products. It provides product development, planning and procurement, and commercial manufacturing services. It also offers marketing services and support solutions to the pharmaceutical companies. The company is headquartered in Hong Kong.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Dickson via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Director/Board Member | |
Galenica AB
![]() Galenica AB Pharmaceuticals: MajorHealth Technology Galenica AB develops and manufactures pharmaceutical drugs. It offers service to partners for the development of oral, dermal, nasal, rectal, pulmonary and parenteral formulations of small molecules to peptides/proteins and biologics. The company was founded in 1999 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
CB Norwood Distributors Ltd.
![]() CB Norwood Distributors Ltd. Wholesale DistributorsDistribution Services CB Norwood Distributors Ltd. distributes farm machinery and equipment. The company was founded by Charles Norwood in 1936 and is headquartered in Palmerstone North, New Zealand. | Wholesale Distributors | Director/Board Member | |
Cape Healthcare Ltd.
![]() Cape Healthcare Ltd. Medical/Nursing ServicesHealth Services Cape Healthcare Ltd. provides healthcare services. The private company is based in Auckland, New Zealand. | Medical/Nursing Services | Director/Board Member | |
GREEN CROSS HEALTH LIMITED | Drugstore Chains | Director/Board Member | |
Pharma Industries Ltd. | Director/Board Member | ||
Cambert (Pilipinas), Inc. | Director/Board Member | ||
Zhha Pty Ltd.
![]() Zhha Pty Ltd. Medical DistributorsDistribution Services Part of EBOS Group Ltd., Zhha Pty Ltd. is a national wholesaler of healthcare services and products with over 3,800 pharmacy customers across Australia. The company is based in Docklands, Australia. With 11 warehouses located around Australia, Symbion coordinates daily deliveries and offers over 16,500 product lines from 800+ manufacturing partners. Symbion is committed to investing in the world's best technologies to increase efficiency for its customers and respond to the future demands of Australia's healthcare landscape. The Australian company's history can be traced back 177 years to when Francis Hardy Faulding opened his first pharmacy in Adelaide in 1845. Zhha was acquired by EBOS Group Ltd. from The Zuellig Group, Inc. on July 05, 2013 for $699.31 million. | Medical Distributors | Director/Board Member | |
EBOS GROUP LIMITED | Medical Specialties | Director/Board Member | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Opterion Health AG
![]() Opterion Health AG Medical/Nursing ServicesHealth Services Opterion Health AG is a Swiss company that focuses on bringing innovation to dialysis care and fostering home dialysis to improve the quality of life for patients suffering from end-stage renal disease (ESRD). Opterion Health is based in Muttenz, CH. The private company aims to increase the survival rates of people with ESRD and reduce healthcare costs. The company was founded in 2012 by Guido Grentzmann, and the CEO is Bjorn Englund. | Medical/Nursing Services | Chairman | |
Actimed Therapeutics Ltd.
![]() Actimed Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Actimed Therapeutics Ltd. is a British clinical stage specialty pharmaceutical company that focuses on bringing innovation to the treatment of muscle wasting disorders. Actimed is based in Ascot, UK. Actimed's lead product, ACM-001 (S-pindolol), targets multiple biological pathways that drive cachexia and has generated promising proof of concept data in a phase II clinical trial in patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). The company is currently preparing for further clinical studies of cachexia in these two cancer types. The company was founded in 2017 by Stefan D. Anker and Andrew Justin Stewart Coats, two world-leading physicians in muscle wasting research, together with Yann Colardelle, a professional in communications and medical education. | Miscellaneous Commercial Services | Chairman | |
SYNLAB AG | Medical/Nursing Services | Chairman | |
SYNLAB International GmbH
![]() SYNLAB International GmbH Medical/Nursing ServicesHealth Services SYNLAB International GmbH offers medical laboratory services for practicing doctors, clinics and the pharmaceutical industry. It offers medical instruments, transfusion medicines, cytology, pathology, human genetics, and general hygiene services. The company was founded by Bartl Wimmer in 1998 and is headquartered in Munich, Germany. | Medical/Nursing Services | Chairman | |
SARTORIUS AG | Pharmaceuticals: Major | Director/Board Member | |
Kyowa Kirin International Plc
![]() Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Soho Flordis International Pty Ltd.
![]() Soho Flordis International Pty Ltd. Pharmaceuticals: OtherHealth Technology Soho Flordis International Pty Ltd. manufactures natural medicine products. Its brands include flordis, ProThera, COMPLEMENTARY, ginsana and KLAIRE LABS. Its products include ginsana, keenmind, nuvexa and gincosan. The company was founded in 2010 and is headquartered in St. Leonards, Australia. | Pharmaceuticals: Other | Director/Board Member | |
VERONA PHARMA PLC | Pharmaceuticals: Major | Chairman | |
OM Pharma SA
![]() OM Pharma SA Pharmaceuticals: MajorHealth Technology OM Pharma SA engages in manufacture of pharmaceutical products. Its portfolio includes products for respiratory tract infections, lower urinary tract infections, chronic venous insufficiency, microangiopathies, hemorrhoids, and menometrorrhagia. The company was founded by Jean-Rene Ricard in 1937 and is headquartered in Meyrin, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Pfizer GmbH | Corporate Officer/Principal | ||
Vifor Pharma Management AG
![]() Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Chairman | |
University of Surrey | College/University | Doctorate Degree | |
Xention Pharma Ltd.
![]() Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member | |
CB Norwood Pty Ltd. | Director/Board Member |
Statistics
International
United Kingdom | 10 |
Germany | 8 |
Australia | 5 |
Switzerland | 5 |
New Zealand | 4 |
Sectoral
Health Technology | 19 |
Health Services | 5 |
Distribution Services | 3 |
Commercial Services | 3 |
Retail Trade | 2 |
Operational
Director/Board Member | 19 |
Chairman | 8 |
Independent Dir/Board Member | 5 |
Chief Executive Officer | 4 |
Corporate Officer/Principal | 3 |
Most connected contacts
Insiders | |
---|---|
David Ebsworth | 26 |
Peter James Williams | 9 |
- Stock Market
- Insiders
- John Dickson
- Company connections